Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „including“
Suchtreffer
Begriffe & Kennungen
Blincyto · 4.8 · Neurologic events including ICANS
Eintrag öffnenBondronat · 4.8 · Anaphylactic reaction/shock Cases of anaphylactic reaction/shock, including fatal events, have been reported i
Eintrag öffnenBondronat · 4.8 · Anaphylactic reaction/shock Cases of anaphylactic reaction/shock, including fatal events, have been reported i
Eintrag öffnenBondronat · 4.8 · Anaphylactic reaction/shock Cases of anaphylactic reaction/shock, including fatal events, have been reported i
Eintrag öffnenBonviva · 4.8 · Anaphylactic reaction/shock Cases of anaphylactic reaction/shock, including fatal events, have been reported i
Eintrag öffnenBonviva · 4.8 · Anaphylactic reaction/shock Cases of anaphylactic reaction/shock, including fatal events, have been reported i
Eintrag öffnenBonviva · 4.8 · Gastrointestinal adverse reactions Patients with a previous history of gastrointestinal disease including pati
Eintrag öffnenBosulif · 4.5 · CYP3A inducers The concomitant use of bosutinib with strong CYP3A inducers (including, but not limited to carb
Eintrag öffnenBosulif · 4.5 · CYP3A inhibitors The concomitant use of bosutinib with strong CYP3A inhibitors (including, but not limited to
Eintrag öffnenBraftovi · 4.8 · Fatigue Melanoma and NSCLC In the Combo 450 ISP, fatigue occurred in 48.1% (179/372) of patients including Gra
Eintrag öffnenBraftovi · 4.8 · Headache Melanoma and NSCLC In the Combo 450 ISP, headache occurred in 18.8% (70/372) of patients, including G
Eintrag öffnenBrilique · 4.5 · A delayed and decreased exposure to oral P2Y12 inhibitors, including ticagrelor and its active metabolite, has
Eintrag öffnenBrilique · 4.5 · A delayed and decreased exposure to oral P2Y12 inhibitors, including ticagrelor and its active metabolite, has
Eintrag öffnenBrilique · 4.5 · A delayed and decreased exposure to oral P2Y12 inhibitors, including ticagrelor and its active metabolite, has
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.8 · Neoplasms Tumour benign, bleedingsa malignant and unspecified (including cysts and polyps)
Eintrag öffnenBrilique · 4.8 · Neoplasms Tumour benign, bleedingsa malignant and unspecified (including cysts and polyps) Blood and Blood dis
Eintrag öffnenBrilique · 4.8 · Neoplasms Tumour benign, bleedingsa malignant and unspecified (including cysts and polyps) Blood and Blood dis
Eintrag öffnen